0001406718-20-000025.txt : 20200518
0001406718-20-000025.hdr.sgml : 20200518
20200518103333
ACCESSION NUMBER: 0001406718-20-000025
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200331
FILED AS OF DATE: 20200518
DATE AS OF CHANGE: 20200518
EFFECTIVENESS DATE: 20200518
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corriente Advisors, LLC
CENTRAL INDEX KEY: 0001406718
IRS NUMBER: 752939516
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-12875
FILM NUMBER: 20888348
BUSINESS ADDRESS:
STREET 1: 1401 FOCH ST
STREET 2: SUITE 100
CITY: FORT WORTH
STATE: TX
ZIP: 76107
BUSINESS PHONE: 8178700400
MAIL ADDRESS:
STREET 1: 1401 FOCH ST
STREET 2: SUITE 100
CITY: FORT WORTH
STATE: TX
ZIP: 76107
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001406718
XXXXXXXX
03-31-2020
03-31-2020
Corriente Advisors, LLC
1401 FOCH ST
SUITE 100
FORT WORTH
TX
76107
13F HOLDINGS REPORT
028-12875
N
Matthew H. Gilman
CFO / CCO
817 870-0404
/s/Matthew Gilman
Fort Worth
TX
05-15-2020
0
11
92638
false
INFORMATION TABLE
2
form13fInfoTable.xml
DESCRIPTION FOR INFORMATION TABLE
APTOSE BIOSCIENCES INCCOM NEW03835T200173332918000SHSOLE1291800000BELLUS HEALTH INC NEWCOM NEW07987C2041484148666SHSOLE114866600CUE BIOPHARMA INCCOM22978P10611636820000SHSOLE182000000EPIZYME INCCOM29428V1043567230000SHSOLE123000000GRAYSCALE BITCOIN ORDCOM3896371094201590000SHSOLE159000000MAXAR TECHNOLOGIES INCCOM57778K105180401689100SHSOLE1168910000PIERIS PHARMACEUTICALS INCCOM72079510340631781921SHSOLE1178192100REATA PHARMACEUTICALS INCCL A75615P10327425190000SHSOLE119000000SCHRODINGER ORDCOM80810D103258760000SHSOLE16000000SUNESIS PHARMACEUTICALS INCCOM86732870012543021692SHSOLE1302169200TESLA INCCOM88160R10110482000SHSOLE1200000